xCures Inc Press Releases - EIN Presswire - Press Release Distribution Service

Published on May 13, 2025 - 13:00 GMT

xCures Achieves HITRUST e1 Certification Demonstrating Commitment to Foundational Cybersecurity

The certification validates xCures’ commitment to rigorous foundational cybersecurity controls and information risk management. OAKLAND, CA, UNITED STATES, May 13, 2025 /⁨EINPresswire.com⁩/ -- xCures, a pioneer in AI-driven healthcare data solutions, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on May 8, 2025 - 14:47 GMT

xCures Joins Civitas Networks for Health

xCures AI Platform transforms medical records into actionable insights to improve patient outcomes. OAKLAND, CA, UNITED STATES, May 8, 2025 /⁨EINPresswire.com⁩/ -- xCures, a pioneer in AI-driven healthcare data solutions, today announced it has joined …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on April 9, 2025 - 13:18 GMT

xCures CEO Mika Newton to Speak on AI-Enhanced Telehealth at ATA Nexus Conference

Newton will discuss leveraging artificial intelligence to effectively deliver guideline-recommended care in telemedicine at the premier digital health event. OAKLAND, CA, UNITED STATES, April 9, 2025 /⁨EINPresswire.com⁩/ -- xCures, a pioneer in AI-driven …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on January 10, 2025 - 21:36 GMT

xCures CEO Mika Newton accepted into Forbes Technology Council

Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs, and technology executives. OAKLAND, CA, UNITED STATES, January 10, 2025 /⁨EINPresswire.com⁩/ -- Mika Newton, the CEO of xCures, a market-leader in medical records …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on July 3, 2024 - 19:02 GMT

Expanded Access Program for gallium maltolate (GaM) Now Open

Investigational cancer treatment with the potential to slow brain tumor growth is now available for patients with relapsed/refractory glioblastoma. OAKLAND, CALIFORNIA, UNITED STATES, July 3, 2024 /⁨EINPresswire.com⁩/ -- xCures, a healthcare data platform …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 28, 2024 - 14:00 GMT

Kidney Cancer Association enters strategic partnership with xCures

The partnership will empower patients with greater control over their health data and accelerate the discovery and approval of new treatments for kidney cancer. OAKLAND, CALIFORNIA, UNITED STATES, May 28, 2024 /⁨EINPresswire.com⁩/ -- Kidney Cancer …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on May 24, 2024 - 11:00 GMT

xCures to showcase the value of its healthcare data platform at the 2024 ASCO Annual Meeting

xCures' patient-centric platform enables outcomes monitoring and evidence generation, providing insights into the best treatments, including for rare cancers. OAKLAND, CALIFORNIA, UNITED STATES, May 24, 2024 /⁨EINPresswire.com⁩/ -- xCures, a leading- …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on March 7, 2024 - 14:00 GMT

xCures Announces Issuance of Groundbreaking Patent

USPTO awards patent for AI tech enabling virtual trials, enhancing clinical decisions through continuous learning from patient experiences. OAKLAND, CALIFORNIA, UNITED STATES, March 7, 2024 /⁨EINPresswire.com⁩/ -- xCures, Inc., a leader in health …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on December 13, 2023 - 15:15 GMT

xCures and Aetion® Further Enhance Partnership with Rich Real-World Datasets

Partnership now includes access to five comprehensive oncology datasets, enhancing real-world evidence in cancer research. OAKLAND, CALIFORNIA, UNITED STATES, December 13, 2023 /⁨EINPresswire.com⁩/ -- In the realm of oncology research, diverse, …

Distribution channels: Business & Economy, Companies ...

Published on December 6, 2023 - 15:15 GMT

xCures to offer clinical data extraction as a service in AWS Marketplace

AWS cloud configurations help xCures customers leverage the company’s data gathering and structuring services while maintaining secure private ownership of data OAKLAND, CALIFORNIA, UNITED STATES, December 6, 2023 /⁨EINPresswire.com⁩/ -- xCures, a …

Distribution channels: Business & Economy, Companies ...

Published on June 20, 2023 - 17:15 GMT

xCures and DDRFA partner to make an impact on patient-driven DIPG & DMG research

xCures’ technology harnesses real-time patient data and makes it accessible for scientific exploration and to improve patient options. OAKLAND, CALIFORNIA, UNITED STATES, June 20, 2023 /⁨EINPresswire.com⁩/ -- Today, xCures and the Diffuse Intrinsic …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on June 6, 2023 - 14:15 GMT

CureMatch and xCures Partner to Revolutionize the Standard for Precision Cancer Treatment Processes

CureMatch will leverage xCures technology that automatically creates a comprehensive outline of a patient’s medical history to improve treatment recommendations OAKLAND, CALIFORNIA, UNITED STATES, June 6, 2023 /⁨EINPresswire.com⁩/ -- CureMatch, Inc., a …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on May 26, 2023 - 14:15 GMT

xCures showcases the Power of its Real-time Clinical data platform at ASCO Annual Meeting 2023

Real-world patient data gives valuable insights, such as collecting data on rare cancers and showing real-world side effects of treatment combinations. OAKLAND, CALIFORNIA, UNITED STATES, May 26, 2023 /⁨EINPresswire.com⁩/ -- xCures, a healthcare …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 15, 2023 - 15:15 GMT

Genome Medical and xCures Partner to Enhance Genetic Services with Personalized Clinical Data

OAKLAND, CALIFORNIA, UNITED STATES, February 15, 2023 /⁨EINPresswire.com⁩/ -- Genome Medical and xCures have joined forces to provide patients with a new level of personalized care. Through this collaboration, Genome Medical's genetic counselors will …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on December 20, 2022 - 15:15 GMT

xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study

RenovoRx's Phase III clinical study is open to pancreatic adenocarcinoma patients and focuses on extending overall survival and improving quality of life. OAKLAND, CALIFORNIA, UNITED STATES, December 20, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. is …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on November 15, 2022 - 11:49 GMT

xCures presents clinical and translational research with two posters at the 2022 SNO Annual Meeting

XCELSIOR registry showcases its power in using real-world datasets and clinical outcomes to aid decision-making and treatment options for CNS cancer patients. OAKLAND, CALIFORNIA, UNITED STATES, November 15, 2022 /⁨EINPresswire.com⁩/ -- Today, xCures …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on November 8, 2022 - 14:45 GMT

Finally, cancer patients have real-time access to their medical records

Recent changes to patients’ data rights enable xCures’ platform to automatically retrieve patient records from institutions and generate powerful care summaries OAKLAND, CALIFORNIA, UNITED STATES, November 8, 2022 /⁨EINPresswire.com⁩/ -- Last month, the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...

Published on October 24, 2022 - 17:39 GMT

xCures and mProbe partner to help cancer patients determine optimal treatments

xCures partners with mProbe, to leverage their targeted proteomics platform for profiling individual patients' cancer tissues for actionable drug targets OAKLAND, CALIFORNIA, UNITED STATES, October 24, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. is …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on August 25, 2022 - 14:05 GMT

xCures and Oblato announce the launch of a Compassionate Use program for OKN-007

Oblato’s first-in-class small molecular OKN-007 will be available through a newly opened compassionate use protocol. OAKLAND, CALIFORNIA, UNITED STATES, August 25, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc., a clinical study platform provider, and Oblato, …

Distribution channels: Business & Economy, Companies ...

Published on August 24, 2022 - 14:05 GMT

Pancreatic Cancer Patients Will Now Have Remote Access to Precision Nutrition Trial Through New Partnership

xCures and Vault Health integration creates a decentralized platform to benefit pancreatic cancer research and facilitate enrollment in Faeth’s NEAAR-001 study OAKLAND, CALIFORNIA, UNITED STATES, August 24, 2022 /⁨EINPresswire.com⁩/ -- xCures, Inc. is …

Distribution channels: Business & Economy, Companies ...